Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Davis

Showing results (201-210 of 505) with videos related to

Pageof 51
Sort By:
Schizophrenia (Heidelberg, Germany)|March 31, 2025
COSMIN review of the PANSS Marder factor solution and other factor models in people with schizophreniaMaximilian Roithmeier, Simon Geck, Markus Bühner, et al.
Biology|June 27, 2024
Peripheral Blood Mononuclear Cell Expression of Cation-Chloride Cotransporter (CCC) Genes in Premenstrual Dysphoric Disorder (PMDD) across the Menstrual Cycle-A Preliminary StudySoojeong Cho, Fatimata Soumare, Sunni L Mumford, et al.
Schizophrenia (Heidelberg, Germany)|February 14, 2024
Are the results of open randomised controlled trials comparing antipsychotic drugs in schizophrenia biased? Exploratory meta- and subgroup analysisStefan Leucht, Spyridon Siafis, Johannes Schneider-Thoma, et al.
Schizophrenia Bulletin|April 11, 2020
Are Randomized Controlled Trials on Pharmacotherapy and Psychotherapy for Positive Symptoms of Schizophrenia Comparable? A Systematic Review of Patient and Study CharacteristicsIrene Bighelli, Claudia Leucht, Maximilian Huhn, et al.
Arthritis Care & Research|May 14, 2014
Time trends in glucocorticoid use in rheumatoid arthritis: results from a population-based inception cohort, 1980-1994 versus 1995-2007Ashima Makol, John M Davis, Cynthia S Crowson, et al.
Schizophrenia Research|February 3, 2007
Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorderMarin Veldic, Bashkim Kadriu, Ekrem Maloku, et al.
Seminars in Arthritis and Rheumatism|September 27, 2022
Association between work physical activity, dietary factors, and risk of rheumatoid arthritisVanessa L Kronzer, Ryan J Lennon, Jeffrey A Sparks, et al.
International Journal of Dermatology|July 4, 2024
Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestationsMuna Shakhashiro, Shadi Sadeghian, Jack Newcomer, et al.
Arthritis Care & Research|January 20, 2026
Impact of Dual Rheumatoid Factor and Anti-Citrullinated Protein Antibody Seropositive, Single Seropositive, and Seronegative Rheumatoid Arthritis on OutcomesRebecca T Brooks, Sara J Achenbach, Vanessa L Kronzer, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 19, 2025
Towards a name change of schizophrenia: Positive and Negative Symptoms Disorder (PND)Stefan Leucht, Deniz S Yurtseven, Josef Priller, et al.
Pageof 51

Showing results (201-210 of 505) with videos related to

Sort By:
Pageof 51
Schizophrenia (Heidelberg, Germany)|March 31, 2025
COSMIN review of the PANSS Marder factor solution and other factor models in people with schizophreniaMaximilian Roithmeier, Simon Geck, Markus Bühner, et al.
Biology|June 27, 2024
Peripheral Blood Mononuclear Cell Expression of Cation-Chloride Cotransporter (CCC) Genes in Premenstrual Dysphoric Disorder (PMDD) across the Menstrual Cycle-A Preliminary StudySoojeong Cho, Fatimata Soumare, Sunni L Mumford, et al.
Schizophrenia (Heidelberg, Germany)|February 14, 2024
Are the results of open randomised controlled trials comparing antipsychotic drugs in schizophrenia biased? Exploratory meta- and subgroup analysisStefan Leucht, Spyridon Siafis, Johannes Schneider-Thoma, et al.
Schizophrenia Bulletin|April 11, 2020
Are Randomized Controlled Trials on Pharmacotherapy and Psychotherapy for Positive Symptoms of Schizophrenia Comparable? A Systematic Review of Patient and Study CharacteristicsIrene Bighelli, Claudia Leucht, Maximilian Huhn, et al.
Arthritis Care & Research|May 14, 2014
Time trends in glucocorticoid use in rheumatoid arthritis: results from a population-based inception cohort, 1980-1994 versus 1995-2007Ashima Makol, John M Davis, Cynthia S Crowson, et al.
Schizophrenia Research|February 3, 2007
Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorderMarin Veldic, Bashkim Kadriu, Ekrem Maloku, et al.
Seminars in Arthritis and Rheumatism|September 27, 2022
Association between work physical activity, dietary factors, and risk of rheumatoid arthritisVanessa L Kronzer, Ryan J Lennon, Jeffrey A Sparks, et al.
International Journal of Dermatology|July 4, 2024
Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestationsMuna Shakhashiro, Shadi Sadeghian, Jack Newcomer, et al.
Arthritis Care & Research|January 20, 2026
Impact of Dual Rheumatoid Factor and Anti-Citrullinated Protein Antibody Seropositive, Single Seropositive, and Seronegative Rheumatoid Arthritis on OutcomesRebecca T Brooks, Sara J Achenbach, Vanessa L Kronzer, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 19, 2025
Towards a name change of schizophrenia: Positive and Negative Symptoms Disorder (PND)Stefan Leucht, Deniz S Yurtseven, Josef Priller, et al.
Pageof 51